Selected through a Dragon's Den-style approach, BCTRCG is currently supporting three diverse projects related to breast cancer patient care.
Brain metastasis is a major cause of breast cancer patient morbidity and mortality.
PRIMROSE is a prospective audit aiming to establish the current management of breast cancer brain metastasis patients in the UK.
A retrospective audit of the practice and outcomes of long term Trastuzumab, in patients with HER2 positive breast cancer, across the UK which could shape the future use of long-term Trastuzumab.
Though uncommon, an increasing number of women are being diagnosed with breast cancer during or soon after pregnancy.
This retrospective audit will describe the current practice of PABC management nationwide.